TC Biopharm (Holdings) Plc (TCBPY)
OTCMKTS
· Delayed Price · Currency is USD
0.2800
-0.0400 (-12.50%)
Apr 2, 2025, 4:00 PM EST
TC Biopharm (Holdings) Statistics
Total Valuation
TCBPY has a market cap or net worth of 131,326. The enterprise value is 951,775.
| Market Cap | 131,326 |
| Enterprise Value | 951,775 |
Important Dates
The next estimated earnings date is Wednesday, April 2, 2025.
| Earnings Date | Apr 2, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TCBPY has 410,393 shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 410,393 |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.04% |
| Owned by Institutions (%) | 1.26% |
| Float | 410,249 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 0.00 |
| P/TBV Ratio | 0.07 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.07 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -0.09 |
Financial Position
The company has a current ratio of 1.12, with a Debt / Equity ratio of 0.83.
| Current Ratio | 1.12 |
| Quick Ratio | 0.64 |
| Debt / Equity | 0.83 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.19 |
| Interest Coverage | -142.89 |
Financial Efficiency
Return on equity (ROE) is -577.04% and return on invested capital (ROIC) is -182.74%.
| Return on Equity (ROE) | -577.04% |
| Return on Assets (ROA) | -98.20% |
| Return on Invested Capital (ROIC) | -182.74% |
| Return on Capital Employed (ROCE) | -354.88% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -356,739 |
| Employee Count | 41 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 0.52 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | 737,384 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.12 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -14.99M |
| Pretax Income | -15.39M |
| Net Income | -14.63M |
| EBITDA | -14.32M |
| EBIT | -14.99M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 1.27 million in cash and 2.09 million in debt, giving a net cash position of -820,451 or -2.00 per share.
| Cash & Cash Equivalents | 1.27M |
| Total Debt | 2.09M |
| Net Cash | -820,451 |
| Net Cash Per Share | -2.00 |
| Equity (Book Value) | 2.53M |
| Book Value Per Share | 102.44 |
| Working Capital | 535,665 |
Cash Flow
In the last 12 months, operating cash flow was -11.17 million and capital expenditures 34,950, giving a free cash flow of -11.13 million.
| Operating Cash Flow | -11.17M |
| Capital Expenditures | 34,950 |
| Free Cash Flow | -11.13M |
| FCF Per Share | -27.13 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TCBPY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -11,137.38% |
| FCF Yield | -8,477.70% |
Stock Splits
The last stock split was on February 10, 2025. It was a reverse split with a ratio of 0.05.
| Last Split Date | Feb 10, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.05 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |